✦ LIBER ✦

Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study

✍ Scribed by Maass, Nicolai; Harbeck, Nadia; Mundhenke, Christoph; LerchenmÃ¼ller, Christian; Barinoff, Jana; LÃ¼ck, Hans-Joachim; Ettl, Johannes; Aktas, Bahriye; KÃ¼mmel, Sherko; RÃ¶sel, Siegfried; Wagner, Steffen; MÃ¼ller, Lothar; Bischoff, Joachim; LÃ¼bbe, Kristina; Schwedler, Kathrin; Schmidt, Marcus; Bauerschlag, Dirk; Nekljudova, Valentina; Minckwitz, Gunter; Loibl, Sibylle

Book ID: 121419964
Publisher: Springer-Verlag
Year: 2013
Tongue: English
Weight: 313 KB
Volume: 139
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-013-1518-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

11 Everolimus (Rad001) as Treatment in B

11 Everolimus (Rad001) as Treatment in Breast Cancer Patients with Bone Metastases Only – First Results of the Multi-centre, Placebo-controlled, Randomized Discontinuation Phase II RADAR Study

✍ N. Harbeck; N. Maass; C. Mundhenke; C. Lerchenmüller; J. Barinoff; J. Etti; B. A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A randomised phase II study of oral pami

A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer

✍ R.E Coleman; S Houston; O.P Purohit; R.D Rubens; A Kandra; J Ford 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 88 KB

2LBA Denosumab versus zoledronic acid fo

2LBA Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study

✍ A. Stopeck; J.J. Body; Y. Fujiwara; A. Lipton; G.G. Steger; M. Viniegra; M. Fan; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Pamidronate infusions as single-agent th

Pamidronate infusions as single-agent therapy for bone metastases: A phase II trial in patients with breast cancer

✍ C.T. Tyrrell; P.P. Bruning; F. May-Levin; C. Rose; L. Mauriac; M. Soukop; J.M. F 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 635 KB

Results of a prospective, randomized, do

Results of a prospective, randomized, double-blind, double-dummy, Phase 3 study comparing denosumab with zoledronic acid for the treatment of breast cancer patients with bone metastases

✍ Jean-Jacques Body; Alison Stopeck; Yasuhiro Fujiwara; Allan Lipton; Guenther Ste 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Incidence of acute phase adverse events

Incidence of acute phase adverse events following denosumab or intravenous bisphosphonates: results from a randomized, controlled phase II study in patients with breast cancer and bone metastases

✍ Cynthia Campbell-Baird; Allan Lipton; Makan Sarkeshik; Haijun Ma; Susie Jun 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 131 KB